Clinical Trials Logo

Low Back Pain clinical trials

View clinical trials related to Low Back Pain.

Filter by:
  • Recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06387589 Recruiting - Low Back Pain Clinical Trials

Effects of Static Stretching Versus Post Facilitation Stretch of Iliopsoas in Non-Specific Low Back Pain

Start date: July 15, 2023
Phase: N/A
Study type: Interventional

This study is a randomized controlled trial and the purpose of this study is to determine the effects of Static Stretching Versus Post Facilitation Stretch of Iliopsoas combined with core stability exercises in Non-Specific Low Back Pain"

NCT ID: NCT06387563 Recruiting - Low Back Pain Clinical Trials

Effects of Abdominal Muscle Activation Training, Using Pressure Biofeedback in Comparison With Surface Electromyography

Start date: November 6, 2023
Phase: N/A
Study type: Interventional

This study is a randomized control trial and the purpose of this study to determine the effects of abdominal muscle activation training on non-specific low back pain; using pressure biofeedback in comparison with surface electromyography biofeedback: a randomized control trial.

NCT ID: NCT06361485 Recruiting - Low Back Pain Clinical Trials

Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Lumbar Pain

Start date: March 25, 2024
Phase: Phase 1
Study type: Interventional

This is a Pilot Study that is an open label, prospective, non-controlled study in which the safety and feasibility of Wharton's Jelly (WJ) allograft will be evaluated in 100 participants suffering with low back pain.

NCT ID: NCT06356844 Recruiting - Low Back Pain Clinical Trials

The Effect of Resolvins on the Resolve of Inflammatory Low Back Pain

Start date: February 27, 2024
Phase: N/A
Study type: Interventional

Brief Summary: Inflammatory back pain is a chronic condition localized in the axial spine and sacroiliac joints.1 It often accompanies mechanical issues like lumbar disc herniation. While non-surgical interventions such as medication, physiotherapy, and epidural steroid injections are typically the initial approach, surgical options may be considered if these prove ineffective.2 Resolvins, derived from omega-3 fatty acids, have shown promise in reducing inflammation and pain. They help to resolve inflammatory responses, promote tissue repair, and decrease disc size, potentially reducing the need for surgery.3,4 This clinical trial aims to evaluate the efficacy of adding oral resolvins to transforaminal epidural steroid injections for treating lumbar disc herniation (LDH) The control group (Group C: n=25) will receive epidural steroids, while the study group (Group R: n=25) will receive both oral omega-3 supplementation and epidural steroids on the same day. Additionally, the study group will continue taking oral omega-3 supplements for six months. The primary outcome measure will be changes in protruded/extruded disc size assessed via MRI, with secondary outcomes including pain levels measured by the Numeric Rating Scale (NRS) and serum cytokine levels (IL-6, IL-17, IL-1 beta, TNF-alpha) over the study period. Discussion: This trial anticipates that combining the anti-inflammatory properties of resolvins with epidural steroid injection will provide a beneficial treatment for patients suffering from inflammatory low back pain.

NCT ID: NCT06355752 Recruiting - Low Back Pain Clinical Trials

Biomarkers of Pain and Stress Perception and Dry Needling Technique Application

Start date: April 12, 2024
Phase: N/A
Study type: Interventional

The use of the dry needling technique has become widespread in recent years for the treatment of musculoskeletal pain. Although dry needling has been shown to be effective in the treatment of shoulder pain, elbow pain, headache, etc., we do not yet have a clear understanding of the mechanisms of action that justify its beneficial effects. In this study, we propose to analyse the biochemical markers of pain generated by the application of a dry needling technique on the lumbar musculature in patients with mechanical lumbar pain of non-specific origin. The aim of this study will be to evaluate the effects of dry needling technique on the plasmatic concentration of biochemical markers.Furthermore, the test subjects will be randomly distributed into two groups. An experimental group where the subjects will receive a real dry needling technique. Another group will be treated with a sham technique.

NCT ID: NCT06355414 Recruiting - Depression Clinical Trials

Psilocybin in Chronic Low Back Pain and Depression

Start date: April 22, 2024
Phase: Phase 1
Study type: Interventional

This study seeks to provide insight on psilocybin's effects on mechanisms of chronic pain among patients with co-morbid chronic low back pain and depression (CLBP+D). Participants will receive either a single high-dose of psilocybin (25mg absolute dose) or methylphenidate (40mg absolute dose). Participants will be asked to complete assessments of pain, depressive symptoms, and more general questionnaires regarding the participants experiences during the experimental sessions and the associated enduring effects.

NCT ID: NCT06345690 Recruiting - Back Pain Clinical Trials

VIA Disc NP Registry 3.0

Start date: February 27, 2024
Phase:
Study type: Observational [Patient Registry]

Registry is to observe and trend patterns of care and outcomes for patients treated with VIA Disc NP.

NCT ID: NCT06342791 Recruiting - Low Back Pain Clinical Trials

Effect of Laser Acupuncture on Menstrual Back Pain

Start date: February 20, 2024
Phase: N/A
Study type: Interventional

effect of laser acupuncture on menstrual back pain

NCT ID: NCT06330961 Recruiting - Low Back Pain Clinical Trials

Effects of Different Kinds of Exercise in Low Back Pain

Start date: January 8, 2024
Phase: N/A
Study type: Interventional

Low back pain is considered one of the great global challenges in public health due to its high prevalence. Exercise have been shown to cause an increase in pain thresholds, through the effect known as exercise-induced hypoalgesia. Little is known about exercise-induced hypoalgesia induced by different modalities of exercise in low back pain, and its possible effects in lumbopelvic biomechanics. The goal of this clinical trial is to compare the effect of exercise-induced hypoalgesia after an isometric, aerobic and a sham/ placebo exercise in non-specific low back pain. The main questions it aims to answer are: - Does an isometric exercise intervention cause exercise-induced hypoalgesia in non-specific low back pain patients? - Is the effect of an isometric exercise intervention comparable to that of aerobic exercise? - Is a placebo/ sham intervention also effective to reduce pain thresholds in these patients? - Do healthy subjects show the same effects in pain thresholds as low back pain patients ? Participants will perform an isometric, aerobic and placebo/ sham exercise intervention in three different recording sessions. Before and after the interventions, pain intensity, pain-pressure thresholds and lumbopelvic biomechanical parameters during trunk flexion-extension will be recorded. Researchers will compare a group of low back pain patients to an age-, gender- and anthropometrics-matched control group of pain-free subjects to see if exercise-induced hypoalgesia is also observed when there is no low back pain diagnosis.

NCT ID: NCT06325631 Recruiting - Clinical trials for Low Back Pain, Mechanical

Comparative Evaluation of the Results of Facet Joint Injections

Start date: January 2, 2023
Phase: N/A
Study type: Interventional

Low back pain affects 60 to 90% of the total population. It is one of the most common causes of disability in adults. Low back pain can be originated from a wide variety of structures, and the facet joint is one of these structures. It is thought that 21 to 41% of low back pain originates from the facet joint. A wide variety of conservative treatments, including intra-articular injections, are used to treat low back pain originating from the facet joint. However, there is still no consensus on the most effective treatment method. With appropriate patient selection, facet joint injections can provide significant improvements in patients' pain scores. After Goldthwait defined the facet joint concept in 1911, Ghormley defined facet joint syndrome in 1933. The source of pain in 40-50% of patients is the lumbar facet joints. Innervation of the lumbar facet joints is provided by the medial branches of the dorsal roots of the spinal nerves. In 1975, Shealy described the coagulation of the articular nerve support of the spinal facet joints with the radiofrequency method. These methods have been further developed over time. The results of facet joint injections are satisfactory in well-selected patient groups. It has been shown that intra-articular steroid injection to the facet joint is superior to systemic steroid use in patients with low back pain. In this study, it was aimed to methodically compare the facet joint injections applied to patients diagnosed with facet syndrome in the outpatient clinic of the Physical Therapy and Rehabilitation Hospital in terms of patient pain scores, application time, effort spent and patient anxiety. Intra-articular injections will be performed under by fluoroscopy or ultrasound guidance or anatomic location.